Evonik unveils beauty innovations at in-cosmetics Asia 2013, Bangkok.
• Evonik at in-cosmetics Asia 2013, Bangkok, Thailand (booth no. G 10), October 29th – 31st
• Evonik’s Personal Care Business Line will showcase product innovations
• Evonik’s technical experts will give a lecture on high performance emulsion stabilization and daylight protection
As a specialist for ingredients and concepts for effective skin care, hair care and body care, Evonik’s Personal Care Business Line combines scientific excellence with passion. At in-cosmetics Asia 2013, Evonik’s Personal Care Business Line will display its most advanced products and novelties. In addition to its booth presence, Evonik will highlight the benefits of high performance emulsifiers for challenging fluid emulsions and of actives for advanced skin protection against environmental stresses. These topics will be presented in expert talks at the Innovation Seminar Theater on October 29th and 30th at 3.00pm.
To better serve the personal care industry in Asia, Evonik is stepping up its regional production capacities with a new organics production facility in Shanghai which is opening on October 28th, 2013. Also, Evonik recently expanded its plant in Indonesia for premium raw materials, additives and ingredients. Manufacturing regionally underlines Evonik’s commitment to provide product solutions tailored to Asian needs.
At in-cosmetics, visitors will have the chance to find out more about the products from Evonik’s Personal Care Business Line, like the PEG-free W/O emulsifier ABIL® EM 120 which is suitable for stabilizing pigment-containing emulsions and color trueness of foundations when applied on skin. TEGO® Care PBS 6, a versatile PEG-free O/W emulsifier, provides emulsification stability of sun care formulations containing a high load of water soluble UV filter. Innovative actives like TEGO® Stemlastin contribute to a youthful skin appearance. Other product highlights include the plant extract TEGO® Cistus, an active ingredient which provides daylight defense with its effective photo protection.
The performance additive TEGO® Carbomer 841 SER, a novel cross-linked polyacrylic acid copolymer designed to control the rheology of surfactant systems, offers high clarity and a synergistic thickening with salt. Completing the innovative portfolio of Evonik’s Personal Care Business Line, ABIL® Soft AF 200 and ABIL® Soft AF 300, two new aminosilicones using advanced manufacturing technology, ensure excellent hair conditioning, superior feel, softness and smoothness.
For more information:
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now has around 3,500 employees in the Greater China region, the regional sales reached over 1 billion in 2012.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.